Peroxisome proliferator activated receptor ligands as regulators of airway inflammation and remodelling in chronic lung disease

PPAR Research

Volumn , Issue , 2007, Pages

  Ward, Jane Elizabeth ^a   Tan, Xiahui ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALLERGEN; CHEMOATTRACTANT; CIGLITAZONE; COLLAGEN; CORTICOSTEROID; CYTOKINE; GLITAZONE DERIVATIVE; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PIRINIXIC ACID; ROSIGLITAZONE; TROGLITAZONE;

AIRWAY HYPERRESPONSIVENESS; AIRWAY RESISTANCE; ASTHMA; CELL FUNCTION; CELL INFILTRATION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CHRONIC LUNG DISEASE; CYTOKINE RELEASE; DRUG MECHANISM; DRUG TARGETING; GLUCOSE METABOLISM; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INFLAMMATION; INFLAMMATORY CELL; LIPID METABOLISM; LUNG ALVEOLUS CELL; LUNG INFILTRATE; MUCUS; NONHUMAN; PATHOLOGY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; TISSUE DISTRIBUTION;

EID: 34548591700     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2007/14983     Document Type: Review

References (89)

1. R. T. Nolte G. B. Wisely S. Westin Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ Nature 395 6698 1998 137 143
2. L. A. Moraes L. Piqueras D. Bishop-Bailey d.bishop-bailey@qmul.ac.uk Peroxisome proliferator-activated receptors and inflammation. Pharmacology and Therapeutics 110 3 2006 371 385
3. E. S. Tien D. B. Hannon J. T. Thompson J. P. Vanden Heuvel Examination of ligand-dependent coactivator recruitment by peroxisome proliferator-activated receptor-α (PPARα). PPAR Research 2006 2006 69612 9 pages
4. J. Berger D. E. Moller The mechanisms of action of PPARs. Annual Review of Medicine 53 2002 409 435
5. B. Desvergne W. Wahli Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocrine Reviews 20 5 1999 649 688
6. D. S. Straus G. Pascual M. Li 15-deoxyΔ12,14-prostaglandin J 2 inhibits multiple steps in the NF-κB signaling pathway. Proceedings of the National Academy of Sciences of the United States of America 97 9 2000 4844 4849
7. P. Gervois philippe.gervois@pasteur-lille.fr N. Vu-Dac R. Kleemann Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor α agonists via inhibition of CCAAT box/enhancer-binding protein β Journal of Biological Chemistry 276 36 2001 33471 33477
8. S. G. Harris R. S. Smith R. P. Phipps 15-deoxy-Δ12,14-PG J 2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway. Journal of Immunology 168 3 2002 1372 1379
9. K. M. Patel K. L. Wright P. Whittaker P. Chakravarty M. L. Watson S. G. Ward S.G.Ward@bath.ac.uk Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPARγ agonists: evidence for disparate functional effects which are independent of NF-κB and PPARγ Cellular Signalling 17 9 2005 1098 1110
10. T. M. Willson tmw20653@glaxowellcome.com P. J. Brown D. D. Sternbach B. R. Henke The PPARs: from orphan receptors to drug discovery. Journal of Medicinal Chemistry 43 4 2000 527 550
11. B. M. Forman P. Tontonoz J. Chen R. P. Brun B. M. Spiegelman R. M. Evans 15-deoxy-Δ12,14-prostaglandin J 2 is a ligand for the adipocyte determination factor PPARγ Cell 83 5 1995 803 812
12. L. C. Bell-Parikh T. Ide J. A. Lawson P. McNamara M. Reilly G. A. FitzGerald garret@spirit.gcrc.upenn.edu Biosynthesis of 15-deoxy-Δ12,14-PG J 2 and the ligation of PPARγ Journal of Clinical Investigation 112 6 2003 945 955
13. L. Benayoun S. Letuve A. Druilhe Regulation of peroxisome proliferator-activated receptor γ expression in human asthmatic airways: relationship with proliferation, apoptosis, and airway remodeling. American Journal of Respiratory and Critical Care Medicine 164 8, part 1 2001 1487 1494
14. C. Faveeuw S. Fougeray V. Angeli Peroxisome proliferator-activated receptor γ activators inhibit interleukin-12 production in murine dendritic cells. FEBS Letters 486 3 2000 261 266
15. J. M. Lehmann L. B. Moore T. A. Smith-Oliver W. O. Wilkison T. M. Willson S. A. Kliewer An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). Journal of Biological Chemistry 270 22 1995 12953 12956
16. G. Chinetti S. Griglio M. Antonucci Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages. Journal of Biological Chemistry 273 40 1998 25573 25580
17. M. Ricote J. Huang L. Fajas Expression of the peroxisome proliferator-activated receptor γ (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proceedings of the National Academy of Sciences of the United States of America 95 13 1998 7614 7619
18. T. J. Standiford tstandif@umich.edu V. G. Keshamouni R. C. Reddy Peroxisome proliferator-activated receptor-γ as a regulator of lung inflammation and repair. Proceedings of the American Thoracic Society 2 3 2005 226 231
19. G. Woerly K. Honda M. Loyens Peroxisome proliferator-activated receptors α and γ down-regulate allergic inflammation and eosinophil activation. Journal of Experimental Medicine 198 3 2003 411 421
20. S. Ueki T. Adachi J. Bourdeaux Expression of PPARγ in eosinophils and its functional role in survival and chemotaxis. Immunology Letters 86 2 2003 183 189
21. M. E. Greene B. Blumberg O. W. McBride Isolation of the human peroxisome proliferator activated receptor γ cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expression 4 4-5 1995 281 299
22. V. Reynders veerlereynders@hotmail.com S. Loitsch sm_loitsch@hotmail.com C. Steinhauer consti24@web.de T. Wagner t.wagner@em.uni-frankfurt.de D. Steinhilber steinhilber@em.uni-frankfurt.de J. Bargon bargon@em.uni-frankfurt.de Peroxisome proliferator-activated receptor α (PPARα) down-regulation in cystic fibrosis lymphocytes. Respiratory Research 7 2006 104
23. P. Gosset A.-S. Charbonnier P. Delerive Peroxisome proliferator-activated receptor γ activators affect the maturation of human monocyte-derived dendritic cells. European Journal of Immunology 31 10 2001 2857 2865
24. R. B. Clark rclark@nso2.uchc.edu D. Bishop-Bailey T. Estrada-Hernandez T. Hla L. Puddington S. J. Padula The nuclear receptor PPARγ and immunoregulation: PPARγ mediates inhibition of helper T cell responses. Journal of Immunology 164 3 2000 1364 1371
25. D. C. Jones X. Ding R. A. Daynes Nuclear receptor peroxisome proliferator-activated receptor α (PPARα) is expressed in resting murine lymphocytes. The PPARα in T and B lymphocytes is both transactivation and transrepression competent. Journal of Biological Chemistry 277 9 2002 6838 6845
26. H. Sugiyama T. Nonaka T. Kishimoto K. Komoriya K. Tsuji T. Nakahata Peroxisome proliferator-activated receptors are expressed in human cultured mast cells: a possible role of these receptors in negative regulation of mast cell activation. European Journal of Immunology 30 12 2000 3363 3370
27. A. C. C. Wang X. Dai B. Luu D. J. Conrad Peroxisome proliferator- activated receptor-γ regulates airway epithelial cell activation. American Journal of Respiratory Cell and Molecular Biology 24 6 2001 688 693
28. A. Trifilieff alexandre.trifilieff@pharma.novartis.com A. Bench M. Hanley D. Bayley E. Campbell P. Whittaker PPAR-α and -γ but not -δ agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-κB-independent effect. British Journal of Pharmacology 139 1 2003 163 171
29. R. Arnold ralf.arnold@medizin.uni-magdeburg.de W. König Peroxisome-proliferator-activated receptor-γ agonists inhibit the release of proinflammatory cytokines from RSV-infected epithelial cells. Virology 346 2 2006 427 439
30. M. Hetzel martin.hetzel@medizin.uni-ulm.de D. Walcher M. Grüb H. Bach V. Hombach N. Marx Inhibition of MMP-9 expression by PPARγ activators in human bronchial epithelial cells. Thorax 58 9 2003 778 783
31. H. A. Burgess L. E. Daugherty T. H. Thatcher PPARγ agonists inhibit TGF-β induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. American Journal of Physiology 288 6 32-6 2005 L1146 L1153
32. H. J. Patel h.j.patel@ic.ac.uk M. G. Belvisi D. Bishop-Bailey M. H. Yacoub J. A. Mitchell Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy. Journal of Immunology 170 5 2003 2663 2669
33. M. Ricote A. C. Li T. M. Willson C. J. Kelly C. K. Glass cglass@ucsd.edu The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391 6662 1998 79 82
34. M. Yamashita may@tohoku-pharm.ac.jp Peroxisome proliferator-activated receptor α-independent effects of peroxisome proliferators on cysteinyl leukotriene production in mast cells. European Journal of Pharmacology 556 1-3 2007 172 180
35. L. Pang linhua.pang@nottingham.ac.uk M. Nie L. Corbett A. J. Knox Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors. Journal of Immunology 170 2 2003 1043 1051
36. S. R. Kim K. S. Lee H. S. Park Involvement of IL-10 in peroxisome proliferator-activated receptor γ-mediated anti-inflammatory response in asthma. Molecular Pharmacology 68 6 2005 1568 1575
37. K. S. Lee S. J. Park P. H. Hwang PPAR-γ modulates allergic inflammation through up-regulation of PTEN. The FASEB Journal 19 8 2005 1033 1035
38. K. Honda P. Marquillies M. Capron D. Dombrowicz Peroxisome proliferator-activated receptor γ is expressed in airways and inhibits features of airway remodeling in a mouse asthma model. Journal of Allergy and Clinical Immunology 113 5 2004 882 888
39. J. T. Huang J. S. Welch M. Ricote Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase. Nature 400 6742 1999 378 382
40. C.-J. Huang I.-M. Liu J.-T. Cheng jtcheng@mail.ncku.edu.tw Increase of peroxisome proliferator-activated receptor δ gene expression in the lungs of streptozotocin-induced diabetic rats. Pulmonary Pharmacology & Therapeutics 20 1 2007 69 74
41. I. Inoue K. Shino S. Noji T. Awata S. Katayama Expression of peroxisome proliferator-activated receptor α (PPARα) in primary cultures of human vascular endothelial cells. Biochemical and Biophysical Research Communications 246 2 1998 370 374
42. J. Becker C. Delayre-Orthez N. Frossard F. Pons pons@pharma.u-strasbg.fr Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases? Fundamental and Clinical Pharmacology 20 5 2006 429 447
43. M. Kobayashi M. J. Thomassen thomasm@ccf.org T. Rambasek An inverse relationship between peroxisome proliferator-activated receptor γ and allergic airway inflammation in an allergen challenge model. Annals of Allergy, Asthma & Immunology 95 5 2005 468 473
44. H. M. Wright C. B. Clish T. Mikami A synthetic antagonist for the peroxisome proliferator-activated receptor γ inhibits adipocyte differentiation. Journal of Biological Chemistry 275 3 2000 1873 1877
45. L. M. Leesnitzer D. J. Parks R. K. Bledsoe Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41 21 2002 6640 6650
46. D. Bishop-Bailey d.bishop-bailey@mds.qmw.ac.uk T. Hla T. D. Warner Bisphenol A diglycidyl ether (BADGE) is a PPARγ agonist in an ECV304 cell line. British Journal of Pharmacology 131 4 2000 651 654
47. K. S. Lee S. R. Kim S. J. Park Peroxisome proliferator activated receptor-γ modulates reactive oxygen species generation and activation of nuclear factor-κB and hypoxia-inducible factor 1α in allergic airway disease of mice. Journal of Allergy and Clinical Immunology 118 1 2006 120 127
48. T. Genovese E. Mazzon R. Di Paola Role of endogenous and exogenous ligands for the peroxisome proliferator-activated receptor α in the development of bleomycin-induced lung injury. Shock 24 6 2005 547 555
49. P. D. G. Miles pmiles@ucsd.edu Y. Barak W. He R. M. Evans J. M. Olefsky Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency. Journal of Clinical Investigation 105 3 2000 287 292
50. K. Maeyama kazu@m.ehime-u.ac.jp M. Emi M. Tachibana Nuclear receptors as targets for drug development: peroxisome proliferator-activated receptor γ in mast cells: its roles in proliferation and differentiation. Journal of Pharmacological Sciences 97 2 2005 190 194
51. D. M. Simon M. C. Arikan S. Srisuma Epithelial cell PPARγ contributes to normal lung maturation. The FASEB Journal 20 9 2006 1507 1509
52. M. G. Belvisi Regulation of inflammatory cell function by corticosteroids. Proceedings of the American Thoracic Society 1 3 2004 207 214
53. M. Nie mszmn1@gwmail.nottingham.ac.uk L. Corbett A. J. Knox L. Pang linhua.pang@nottingham.ac.uk Differential regulation of chemokine expression by peroxisome proliferator-activated receptor γ agonists: interactions with glucocorticoids and β2-agonists. Journal of Biological Chemistry 280 4 2005 2550 2561
54. R. Cunard M. Ricote D. DiCampli Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors. Journal of Immunology 168 6 2002 2795 2802
55. S. G. Harris R. P. Phipps Prostaglandin D 2, its metabolite 15-d-PG J 2, and peroxisome proliferator activated receptor-γ agonists induce apoptosis in transformed, but not normal, human T lineage cells. Immunology 105 1 2002 23 34
56. C. Mueller V. Weaver J. P. Vanden Heuvel A. August axa45@psu.edu M. T. Cantorna mxc69@psu.edu Peroxisome proliferator-activated receptor γ ligands attenuate immunological symptoms of experimental allergic asthma. Archives of Biochemistry and Biophysics 418 2 2003 186 196
57. Y. Fu fuy@musc.edu N. Luo M. F. Lopes-Virella Upregulation of interleukin-8 expression by prostaglandin D 2 metabolite 15-deoxy-Δ12,14 prostaglandin J 2 (15d-PG J 2) in human THP-1 macrophages. Atherosclerosis 160 1 2002 11 20
58. C. Jiang A. T. Ting B. Seed seed@molbio.mgh.harvard.edu PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391 6662 1998 82 86
59. Y. Kobayashi S. Ueki G. Mahemuti Physiological levels of 15-deoxy-Δ12,14-prostaglandin J 2 prime eotaxin-induced chemotaxis on human eosinophils through peroxisome proliferator-activated receptor-γ ligation. Journal of Immunology 175 9 2005 5744 5750
60. C. E. Brightling P. Bradding F. A. Symon S. T. Holgate A. J. Wardlaw I. D. Pavord Mast-cell infiltration of airway smooth muscle in asthma. New England Journal of Medicine 346 22 2002 1699 1705
61. Y. Fujimura H. Tachibana tatibana@agr.kyushu-u.ac.jp K. Yamada Peroxisome proliferator-activated receptor ligands negatively regulate the expression of the high-affinity IgE receptor FcεRI in human basophilic KU812 cells. Biochemical and Biophysical Research Communications 297 2 2002 193 201
62. K. Okuyama M. Yamashita Y. Kitabatake S. Kawamura M. Takayanagi I. Ohno iohno@tohoku-pharm.ac.jp Ciglitazone inhibits the antigen-induced leukotrienes production independently of PPARγ in RBL-2H3 mast cells. European Journal of Pharmacology 521 1-3 2005 21 28
63. M. C. Liu D. Proud L. M. Lichtenstein Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects. Journal of Allergy and Clinical Immunology 108 1 2001 29 38
64. A. Momoi K. Murao mkoji@kms.ac.jp H. Imachi Thiazolidinedione inhibits production of RANTES in a cytokine-treated human lung epithelial cell line. FEBS Letters 452 3 1999 301 304
65. C. Desmet B. Warzée P. Gosset Pro-inflammatory properties for thiazolidinediones. Biochemical Pharmacology 69 2 2005 255 265
66. K. Subbaramaiah ksubba@med.cornell.edu D. T. Lin J. C. Hart A. J. Dannenberg Peroxisome proliferator-activated receptor γ ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300. Journal of Biological Chemistry 276 15 2001 12440 12448
67. J. Bousquet P. Chanez J. Y. Lacoste Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. Journal of Allergy and Clinical Immunology 88 4 1991 649 660
68. M. Ebina T. Takahashi T. Chiba M. Motomiya Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. American Review of Respiratory Disease 148 3 1993 720 726
69. P. G. Woodruff woodruf@itsa.ucsf.edu G. M. Dolganov R. E. Ferrando Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. American Journal of Respiratory and Critical Care Medicine 169 9 2004 1001 1006
70. R. J. Thomson A. M. Bramley R. R. Schellenberg Airway muscle stereology: implications for increased shortening in asthma. American Journal of Respiratory and Critical Care Medicine 154 3, part 1 1996 749 757
71. J. K. Burgess janette@pharmacol.usyd.edu.au B. G. G. Oliver M. H. Poniris A phosphodiesterase 4 inhibitor inhibits matrix protein deposition in airways in vitro. Journal of Allergy and Clinical Immunology 118 3 2006 649 657
72. A. Ialenti G. Grassia P. Di Meglio P. Maffia M. Di Rosa A. Ianaro ianaro@unina.it Mechanism of the anti-inflammatory effect of thiazolidinediones: relationship with the glucocorticoid pathway. Molecular Pharmacology 67 5 2005 1620 1628
73. M. A. Saunders J. A. Mitchell P. M. Seldon Release of granulocyte-macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone. British Journal of Pharmacology 120 4 1997 545 546
74. M. G. Belvisi M. Saunders M. Yacoub J. A. Mitchell Expression of cyclo-oxygenase-2 in human airway smooth muscle is associated with profound reductions in cell growth. British Journal of Pharmacology 125 5 1998 1102 1108
75. J. E. Ward janeew@unimelb.edu.au H. Gould T. Harris J. V. Bonacci A. G. Stewart PPARγ ligands, 15-deoxy-Δ2,14-prostaglandin J 2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms. British Journal of Pharmacology 141 3 2004 517 525
76. D. Fernandes E. Guida V. Koutsoubos Glucocorticoids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracellular-regulated kinases in human cultured airway smooth muscle. American Journal of Respiratory Cell and Molecular Biology 21 1 1999 77 88
77. P. R. A. Johnson J. K. Burgess P. A. Underwood Extracellular matrix proteins modulate asthmatic airway smooth muscle cell proliferation via an autocrine mechanism. Journal of Allergy and Clinical Immunology 113 4 2004 690 696
78. C. Delayre-Orthez orthez@pharma.u-strasbg.fr J. Becker becker@pharma.u-strasbg.fr I. Guenon isabelle.guenon@rennes.inserm.fr PPARα downregulates airway inflammation induced by lipopolysaccharide in the mouse. Respiratory Research 6 2005 91
79. J. E. Ward janeew@unimelb.edu.au D. J. Fernandes C. C. Taylor J. V. Bonacci L. Quan A. G. Stewart The PPARγ ligand, rosiglitazone, reduces airways hyperresponsiveness in a murine model of allergen-induced inflammation. Pulmonary Pharmacology & Therapeutics 19 1 2006 39 46
80. T. Genovese S. Cuzzocrea salvator@unime.it R. Di Paola Effect of rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J 2 on bleomycin-induced lung injury. European Respiratory Journal 25 2 2005 225 234
81. A. Trifilieff A. El-Hashim C. Bertrand Time course of inflammatory and remodeling events in a murine model of asthma: effect of steroid treatment. American Journal of Physiology 279 6 2000 L1120 L1128
82. S. Y. Lee J. S. Kim J. M. Lee Inhaled corticosteroid prevents the thickening of airway smooth muscle in murine model of chronic asthma. to appear in Pulmonary Pharmacology & Therapeutics
83. C. Ward chris.ward@ncl.ac.uk H. Walters Airway wall remodelling: the influence of corticosteroids. Current Opinion in Allergy and Clinical Immunology 5 1 2005 43 48
84. J. Bates C. Irvin V. Brusasco The use and misuse of Penh in animal models of lung disease. American Journal of Respiratory Cell and Molecular Biology 31 3 2004 373 374
85. M. A. Birrell C. H. Battram P. Woodman K. McCluskie M. G. Belvisi m.belvisi@ic.ac.uk Dissociation by steroids of eosinophilic inflammation from airway hyperresponsiveness in murine airways. Respiratory Research 4 2003 3
86. P. J. Henry phenry@receptor.pharm.uwa.edu.au A. D'Aprile G. Self T. Hong T. S. Mann Inhibitors of prostaglandin transport and metabolism augment protease-activated receptor-2-mediated increases in prostaglandin E 2 levels and smooth muscle relaxation in mouse isolated trachea. Journal of Pharmacology and Experimental Therapeutics 314 3 2005 995 1001
87. H. Cho H.-H. Tai Thiazolidinediones as a novel class of NAD +-dependent 15-hydroxyprostaglandin dehydrogenase inhibitors. Archives of Biochemistry and Biophysics 405 2 2002 247 251
88. H. Hammad h.hammad@erasmusmc.nl H. J. de Heer T. Soullié Activation of peroxisome proliferator-activated receptor-γ in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma. American Journal of Pathology 164 1 2004 263 271
89. Y. Hashimoto K. Nakahara Improvement of asthma after administration of pioglitazone. Diabetes Care 25 2 2002 401